Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic.
Journal
Cutis
ISSN: 2326-6929
Titre abrégé: Cutis
Pays: United States
ID NLM: 0006440
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
entrez:
7
6
2021
pubmed:
8
6
2021
medline:
22
6
2021
Statut:
ppublish
Résumé
Cutaneous manifestations of COVID-19-SARS-CoV-2-are common and varied. Morbilliform, vesicular, and urticarial eruptions may be nonspecific initial features of the disease. Chilblainlike lesions on the fingers or toes typically occur as part of a resolution phase, signifying a milder course, whereas livedoid lesions and retiform purpura are associated with coaguloapthy and more severe disease. Additionally, a severe Kawasaki-like multisystem inflammatory syndrome rarely is seen in children. This diverse range of cutaneous manifestations in COVID-19 reflects a spectrum of host immunologic responses to SARS-CoV-2 and may inform disease pathophysiology.
Identifiants
pubmed: 34096848
pii: cutis.0230
doi: 10.12788/cutis.0230
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM